Canopy Growth Expands to UK Medical Cannabis Market with Distribution Agreement

Canadian cannabis producer Canopy Growth has entered the UK medical cannabis market through a distribution partnership with GROW Group, supplying four Canadian-grown flower strains to British patients. This strategic expansion strengthens Canopy's presence in the European medical cannabis sector, which is experiencing growing regulatory acceptance and patient access. The agreement demonstrates the increasing legitimacy of medical cannabis as a therapeutic option in established healthcare markets. UK physicians can now access Canopy's cultivated products for patients with qualifying medical conditions, contributing to the broader availability of regulated medical cannabis alternatives.